It's been over 2 years since Cold Iron Studios first teased the follow-up to Aliens: Fireteam Elite when Elena Siegman and Kendall Deacon Davis were announced to be joining the studio, with the ...
SAN DIEGO, April 13, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc., a biotechnology company pioneering molecular glue degraders to address previously undruggable proteins, today announced the closing of a ...
The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, April 13, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc., a biotechnology company pioneering molecular glue ...
San Diego startup Neomorph on Monday announced a new $100 million investment for its molecular glue that tricks cancer cells into self-destructing. Even as it awaits results from its first clinical ...
Presentation in the New Drugs on the Horizon session to feature the development of NEO-811, a novel ARNT (HIF-1β)-targeted therapy in clear cell renal cell carcinoma (ccRCC) Three additional ...
A research team has developed a new approach to detecting life beyond Earth that does not rely on identifying specific biological markers. Instead, the study suggests that life may be detectable ...
'Disclosure Day' to hit cinemas in June Movie inspired by real-life UFO reports from 2017 Christopher Nolan promotes his summer film, 'The Odyssey' LAS VEGAS, April 15 (Reuters) - Steven Spielberg ...
Alien: Romulus is the latest entry in 20th Century's 45-year-old sci-fi/horror series. Romulus, set between the first two Alien movies, comes from writer-director Fede Alvarez, who previously wrote ...
Do aliens exist? Could Earth really be the only planet hosting intelligent life? Debates over the existence of extraterrestrials date back to the earliest Indigenous and western thought. The tools ...
The filmmaker made his first-ever appearance on the CinemaCon stage in Las Vegas for his upcoming Universal film about the UFO/UAP phenomena. By Ryan Gajewski, James Hibberd Steven Spielberg took the ...
Beeline Medicines has formally launched with $300 million in Series A financing, led by Bain Capital, and a pipeline of drugs for immunology and inflammation therapies licensed from Bristol Myers ...